Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Peripheral Embolic Protection Devices are used to capture and remove plaque debris that is dislodged during interventional interventions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the peripheral embolic protection devices devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the peripheral embolic protection devices market in China was Abbott Laboratories followed by Medtronic, Boston Scientific and Cordis.
Peripheral Embolic Protection Devices used in the lower extremity, carotid and renal arteries are included here. Carotid-Specific Embolic Protection Devices and Carotid and Lower Extremity Embolic Protection Devices are tracked under Peripheral Embolic Protection Devices. A Carotid-Specific Embolic Protection Device is used during the removal of plaque by an interventional intervention on the carotid artery. A Carotid and Lower Extremity Embolic Protection Device is used during a peripheral angioplasty in the lower extremity region. Lower Extremity Embolic Protection Devices can also be used for interventions performed on the carotid artery.
The value of the peripheral embolic protection devices devices market within China was expected to be over $20m in 2023.
For the latest complete market share analysis of peripheral embolic protection devices device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
